Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000347675

Medchemexpress LLC 4-(3-Chloro-4-(3-(cyclopropyl-2,2,3,3-d4)ureido)phenoxy)-7-methoxyquinoline-6-carboxamide-15N | 98.01% | 431.87 | 25 MG
SDP

Supplier:  Medchemexpress LLC 25MGHY10981S2

Encompass_Preferred

Lenvatinib-15N,d4 is a 15N and deuterated labeled version of Lenvatinib. Lenvatinib (E7080) is an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, and exhibits potent antitumor activities.

  • Isotope-labeled compound
  • Deuterated and 15N labeled
  • Oral, multi-targeted tyrosine kinase inhibitor
  • Inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET
  • Shows potent antitumor activities

Catalog No. 50-003-47675


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.